Gregory W. Schafer, a member of the Board of Directors of Capricor Therapeutics, Inc., has notified the company that he will not stand for re-election when his term on the Board expires at the company's 2016 Annual Meeting of Stockholders, which is scheduled for June 2, 2016. Mr. Schafer will continue to serve as a member of the Board, as the Chairman of the Audit Committee of the Board and as a member of the Nominating and Corporate Governance Committee of the Board until the Annual Meeting. Mr. Schafer's decision not to stand for re-election is not due to any disagreement with the Company on any of the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 USD | -1.65% | -10.02% | -2.66% |
11/06 | Sector Update: Health Care Stocks Decline Tuesday Afternoon | MT |
11/06 | Capricor Says FDA Grants Pre-BLA Meeting Request for Duchenne Muscular Dystrophy Treatment; Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.66% | 15Cr | |
+15.85% | 12TCr | |
+18.91% | 11TCr | |
+4.43% | 2.28TCr | |
-18.63% | 2.07TCr | |
-13.76% | 1.64TCr | |
-16.61% | 1.65TCr | |
-43.53% | 1.58TCr | |
+1.75% | 1.35TCr | |
+28.07% | 1.17TCr |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Gregory W. Schafer Not Stand for Re-Election as Member of the Board of Directors of Capricor Therapeutics, Inc